- Release Date: 04/02/26 17:07
- Summary: Neuren receives US FDA meeting feeback for HIE and PTHS
- Price Sensitive: Yes
- Download Document 182.36KB
- Forums
- ASX - By Stock
- Ann: Neuren receives US FDA meeting feeback for HIE and PTHS
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.67%
!
$11.75
Ann: Neuren receives US FDA meeting feeback for HIE and PTHS
-
Top Stories
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|
|||||
|
Last
$11.75 |
Change
-0.200(1.67%) |
Mkt cap ! $1.512B | |||
| Open | High | Low | Volume |
| $11.80 | $11.97 | $11.60 | 410.9K |
Buyers (Bids)
| Vol. | Price($) |
|---|---|
| 427 | $11.75 |
Sellers (Offers)
| Price($) | Vol. |
|---|---|
| $11.82 | 3541 |
| Last trade - 16.25pm 13/03/2026 (20 minute delay) ? |
Featured News
| NEU (ASX) Chart |